Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis: Studies in mice with K/BxN serum-induced arthritis

Arthritis and Rheumatism

Volumn 65, Issue 7, 2013, Pages 1736-1746

  Isozaki, Takeo ^a   Arbab, Ali S ^b   Haas, Christian S ^a   Amin, M Asif ^a   Arendt, Monica D ^a   Koch, Alisa E ^a,c,d   Ruth, Jeffrey H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d Lilly USA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; HEMOGLOBIN; INTERLEUKIN 1BETA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CHIMERA; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MEDIATOR; MICROVASCULAR ENDOTHELIAL CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SCID MOUSE; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE; TISSUE GRAFT; UMBILICAL CORD BLOOD; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CHEMOKINE CXCL6; CHEMOKINES, CXC; CHEMOTAXIS; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, SCID; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION; STEM CELLS; SYNOVIAL MEMBRANE;

EID: 84879859034     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37981     Document Type: Article

References (28)

1. Firestein GS,. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-61.
2. Corrigall VM, Panayi GS,. Autoantigens and immune pathways in rheumatoid arthritis. Crit Rev Immunol 2002; 22: 281-93.
3. Paleolog EM,. Angiogenesis in rheumatoid arthritis. Arthritis Res 2002; 4 Suppl 3: S81-90.
4. Folkman J, Haudenschild C,. Angiogenesis by capillary endothelial cells in culture. Trans Ophthalmol Soc U K 1980; 100: 346-53.
5. Masuda H, Asahara T,. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003; 58: 390-8.
6. Haas CS, Amin MA, Ruth JH, Allen BL, Ahmed S, Pakozdi A, et al. In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum 2007; 56: 2535-48.
7. Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE,. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 2001; 159: 1521-30.
8. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-801.
9. Szekanecz Z, Koch AE,. Chemokines and angiogenesis. Curr Opin Rheumatol 2001; 13: 202-8.
10. Chamberlain G, Wright K, Rot A, Ashton B, Middleton J,. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One 2008; 3: e2934.
11. Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK III, et al. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 2006; 54: 765-78.
12. Distler JH, Beyer C, Schett G, Luscher TF, Gay S, Distler O,. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases [review]. Arthritis Rheum 2009; 60: 3168-79.
13. Silverman MD, Haas CS, Rad AM, Arbab AS, Koch AE,. The role of vascular cell adhesion molecule 1/very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum 2007; 56: 1817-26.
14. Moore XL, Lu J, Sun L, Zhu CJ, Tan P, Wong MC,. Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther 2004; 11: 811-8.
15. Katschke KJ Jr, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1022-32.
16. Ruth JH, Rottman JB, Katschke KJ Jr, Qin S, Wu L, LaRosa G, et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001; 44: 2750-60.
17. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE,. Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001; 167: 1644-53.
18. Kumar P, Hosaka S, Koch AE,. Soluble E-selectin induces monocyte chemotaxis through Src family tyrosine kinases. J Biol Chem 2001; 276: 21039-45.
19. Ruth JH, Volin MV, Haines GK III, Woodruff DC, Katschke KJ Jr, Woods JM, et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 2001; 44: 1568-81.
20. Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, et al. The K/BxN mouse model of inflammatory arthritis: theory and practice. Methods Mol Med 2007; 136: 269-82.
21. Woods JM, Katschke KJ, Volin MV, Ruth JH, Woodruff DC, Amin MA, et al. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol 2001; 166: 1214-22.
22. Ruth JH, Amin MA, Woods JM, He X, Samuel S, Yi N, et al. Accelerated development of arthritis in mice lacking endothelial selectins. Arthritis Res Ther 2005; 7: R959-70.
23. Koch AE,. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003; 62 Suppl 2: ii60-7.
24. Peacock DJ, Banquerigo ML, Brahn E,. Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 1992; 175: 1135-8.
25. Jodon de Villeroche V, Avouac J, Ponceau A, Ruiz B, Kahan A, Boileau C, et al. Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res Ther 2010; 12: R27.
26. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
27. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N,. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005; 52: 3004-14.
28. Mellick AS, Plummer PN, Nolan DJ, Gao D, Bambino K, Hahn M, et al. Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth. Cancer Res 2010; 70: 7273-82.